Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2. - Wikidata - wikimedia - TriplyDB

Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2.

Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2.

http://www.wikidata.org/entity/Q43035115

about

Hepatitis C virus and type 2 diabetes Hepatitis C Virus, Insulin Resistance, and Steatosis Hepatitis C and insulin action: An intimate relationship Molecular mechanisms of insulin resistance in chronic hepatitis C Value of Treating All Stages of Chronic Hepatitis C: A Comprehensive Review of Clinical and Economic Evidence Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.Reduction of insulin resistance with effective clearance of hepatitis C infection: results from the HALT-C trial Importance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitization Prevalence of type 2 diabetes in Algerian patients with hepatitis C virus infection Relationship of hepatitis C virus infection with diabetes in the U.S. population.Insulin resistance and chronic liver disease.HOMA, BMI, and Serum Leptin Levels Variations during Antiviral Treatment Suggest Virus-Related Insulin Resistance in Noncirrhotic, Nonobese, and Nondiabetic Chronic Hepatitis C Genotype 1 Patients.Comparison of surrogate and direct measurement of insulin resistance in chronic hepatitis C virus infection: impact of obesity and ethnicity The Mechanism of Interferon Refractoriness During Hepatitis C Virus Infection and Its Reversal with a Peroxisome Proliferator-Activated Receptor α Agonist Impact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin action RNA-sequencing analysis of 5' capped RNAs identifies many new differentially expressed genes in acute hepatitis C virus infection Motor vehicle accidents: how should cirrhotic patients be managed?Metabolic disorders and steatosis in patients with chronic hepatitis C: metabolic strategies for antiviral treatments.Diabetes and Hepatitis C: A Two-Way Association.Hepatitis C virus infection and nonalcoholic steatohepatitis Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study.Dipeptidyl peptidase-4: a key player in chronic liver disease.Changes of serum omentin-1 levels and relationship between omentin-1 and insulin resistance in chronic hepatitis C patients.Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3 Application of network construction to estimate functional changes to insulin receptor substrates 1 and 2 in Huh7 cells following infection with the hepatitis C virus Improvement in the Amino Acid Imbalance in Hepatitis C Virus Infected Patients After Viral Eradication by Interferon Treatment.Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.Retrospective study of the associations between hepatitis C virus infection and metabolic factors.Hepatitis C and diabetes: the inevitable coincidence?Hepatitis C eradication with sofosbuvir leads to significant metabolic changes.Interaction between hepatitis C virus and metabolic factors.Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review.The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients.Organelle dysfunction in hepatitis C virus-associated steatosis: anything to learn from nonalcoholic steatohepatitis?Current understanding of insulin resistance in hepatitis C.Use of HOMA-IR in hepatitis C.Steatosis and insulin resistance in response to treatment of chronic hepatitis C.Hepatitis C virus induced insulin resistance impairs response to anti viral therapy.The hepatitis C virus infection as a systemic disease.

P2860

Q24658049-6496F8B9-5B0A-4876-AD01-FA0ED0F7EBD6 Q26751755-21834B62-E2AC-406B-941F-F8468823315B Q26775000-B9DACBE1-CEEC-4C46-9F21-0C808857522F Q27489665-AF52C88A-DCAA-42CE-889B-B0E6B4929A97 Q28072257-D32C3959-8696-43D9-8100-7D1F554E78F6 Q28079826-0A60FD9A-5449-4932-9835-F706DF3E80E3 Q30360538-B7E2DE4D-E0B3-4991-B592-6431560CD50B Q33798375-38409D89-772D-47C2-9E20-5AC141E2EAE5 Q33812148-44B694AF-3159-4D13-947A-35A1248F2D51 Q33998662-A1742E2B-CCD7-4A55-B041-FE3E7EACCB22 Q34005936-C087BFCD-453B-4415-AAB7-F763A484DB98 Q35073012-3D51F88B-3063-4F87-B8BE-40F63AC169FD Q35188071-905B7BA4-97A6-4CB6-ACB9-8B75CE0C3A08 Q35346377-A0DEF73B-AB44-4C76-8921-A90BED312F73 Q35814700-DA757A0C-C4CA-47B0-B046-FBC06596322B Q35898216-C3C12E71-8E16-4580-88F1-F611430B3CDD Q35943663-A7FECFE2-B50D-4B6B-89AD-5B5565ECA0D4 Q36015996-7A3101FA-B6CB-4973-BDC6-EE21A4424363 Q36026554-5F1F7B3A-160E-4179-9FCC-1D93522A9E6C Q36056076-FE058E5A-A262-4FAA-AE63-2D0F55161030 Q36179898-1A1D001B-DEC7-4574-AF39-9ED4DEEB9F03 Q36379566-77331BE1-FAC3-4098-A691-40A02083A73F Q36783164-49FB7EEE-5C90-4916-B207-441FC077233C Q36786928-80C3AC7A-AEB0-48F7-AF44-97E7A13B2A75 Q37155511-7EFDF357-9B0B-4568-8818-CCF82B414083 Q37190820-BC89B07D-C8E8-42B8-B3AE-8FEE6D06687D Q37231217-BF9342ED-516D-44B9-BE94-AE5C71C2DD6E Q37345868-95CD32F1-8492-4966-A515-805FC0C6E73F Q37374053-8EE21098-703A-43CF-A52E-122978B0F038 Q37432092-9B6182F7-A353-4E6A-8F49-1785A3F94FA9 Q37513094-43D05015-1D58-4E07-B7E9-977212DD2C60 Q37654443-8B10BB97-B6D2-4F84-8724-E1DFD3510026 Q37685491-7C95AF38-E554-4ED3-BB90-58F5FBA62B3B Q37711317-F5C43F1C-6720-430F-A4E9-EC38DF67C837 Q37863141-958C1EAD-7482-4420-98B5-FF64C9128970 Q37903853-1FC0C0AA-0136-4807-8734-F9689516E2E3 Q37931383-2BC85BAD-DD26-4058-9E35-EDC708FCC5D1 Q37974700-31E11B32-E409-4F89-917B-93F01588FA91 Q37980432-0C4D4821-7523-430E-8FBA-E7ECC91986CB Q38052844-66ECC183-BC9C-44F0-BE53-BE2A08175817

P2860

Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2.

http://www.wikidata.org/entity/Q43035115

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Clearance of HCV improves insu ...... in receptor substrate 1 and 2.

@en

Clearance of HCV improves insu ...... in receptor substrate 1 and 2.

@nl

type

label

Clearance of HCV improves insu ...... in receptor substrate 1 and 2.

@en

Clearance of HCV improves insu ...... in receptor substrate 1 and 2.

@nl

prefLabel

Clearance of HCV improves insu ...... in receptor substrate 1 and 2.

@en

Clearance of HCV improves insu ...... in receptor substrate 1 and 2.

@nl

P1433

Q43035115-52FEA89C-A30F-416B-B63C-0AAF968DAA61

P1476

Q43035115-94883163-0E03-4F44-B6C6-14E29EB4F47A

P2093

Q43035115-1BD54673-659F-469E-A3B1-ED507184C077

Q43035115-3EBFC33C-CC67-4940-AA56-41FE4BAA43BD

Q43035115-64B54AA6-C080-4096-9945-D72A9EB48A20

Q43035115-917F8AFA-1526-4469-8141-202FF46F9CFF

Q43035115-B55C35C6-40CD-427D-984B-1C9E36104003

Q43035115-BE450D13-B871-408A-BBEE-B2A4C52B9F53

Q43035115-C10A356F-50AE-4E48-9A65-31089C12651D

Q43035115-D68E385C-1484-4569-91B1-54CDFE9F6A6D

Q43035115-DE6D4B88-4ECF-4141-B564-C2D5AEE7D9E1

Q43035115-E18B7488-4472-4277-BCE6-886161716EE5

P304

Q43035115-DFFC80DF-764A-49DA-8738-618B3F9BACE1

P31

Q43035115-348878E0-35A9-4D9D-9A15-2B23DBBB3B51

P356

Q43035115-ABBB366C-C253-467B-8164-B9B24ADC9B87

P407

Q43035115-D2826ADE-A8E5-4245-9762-4E97FFDF51D3

P433

Q43035115-A593BB96-9F65-4BE9-A810-7DF146B0004A

P478

Q43035115-3D91DE6F-BE60-4EAB-8D41-09A2428EAD16

P577

Q43035115-BB6E2092-C6F7-402A-8BB8-35C9DD186CFF

P698

Q43035115-BC03BEEB-C4A7-4637-BEF1-DEB730E8B468

P921

Q43035115-5DF3A0C9-92F0-42B9-B737-4951273C63E7

P356

J.1572-0241.2006.01038.X

P1433

The American Journal of Gastroenterology

P1476

Clearance of HCV improves insu ...... in receptor substrate 1 and 2.

@en

P2093

Chikatoshi Yanagimoto

http://www.w3.org/2001/XMLSchema#string

Eiichi Hirano

http://www.w3.org/2001/XMLSchema#string

Eitaro Taniguchi

http://www.w3.org/2001/XMLSchema#string

Hironori Koga

http://www.w3.org/2001/XMLSchema#string

Michio Sata

http://www.w3.org/2001/XMLSchema#string

Minoru Itou

http://www.w3.org/2001/XMLSchema#string

Shinichiro Hanada

http://www.w3.org/2001/XMLSchema#string

Shuji Sumie

http://www.w3.org/2001/XMLSchema#string

Takumi Kawaguchi

http://www.w3.org/2001/XMLSchema#string

Tatsuya Ide

http://www.w3.org/2001/XMLSchema#string

P304

570-576

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1572-0241.2006.01038.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17222321

http://www.w3.org/2001/XMLSchema#string

P921